| Sign In to gain access to subscriptions and/or personal tools. |
Familial antiphospholipid antibodies and acquired circulating anticoagulantsDepartment of Internal Medicine, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon
Division of Rheumatology, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon
Division of Hematology/Oncology, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon
Department of Internal Medicine, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon
Division of Rheumatology, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon
Division of Hematology/Oncology, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon ataher{at}aub.edu.lb, ali.taher{at}aub.edu.lb Familial clustering of elevated antiphospholipid antibody levels has been described, but the reports are heterogeneous with regard to the characterization of the antiphospholipid syndrome (APS), coexisting autoimmune diseases and clinical implications. We report a familial occurrence of APS in two patients, in the presence of SLE in the mother and absence of autoimmune diseases in the daughter along with acquired circulating inhibitors in both cases: platelet inhibitor and factor IX inhibitor, respectively.
Key Words: factor IX inhibitor familial antiphospholipid syndrome platelet inhibitor prolonged bleeding time
Lupus, Vol. 13, No. 10,
812-814 (2004) This article has been cited by other articles:
|
|||||||||||||||
